DS
VERA icon

DRW Securities’s Vera Therapeutics VERA Stock Holding History

DRW Securities’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Sell
7,274
-1,521
-17% -$56.7K 0.01% 593
2026
Q1 		$354K Buy
+8,795
New +$379K ﹤0.01% 804

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DRW Securities's VERA Position: Q2 2026 in Review

DRW Securities reduced its Vera Therapeutics (VERA) stake by 17% in Q2 2026, selling an estimated $56.7K and leaving 7,274 shares worth $312K. The position accounts for 0.01% of the portfolio, ranked #593.

DRW Securities first reported a position in VERA in Q1 2026 and has held it in 2 quarters since. The position peaked at $354K in Q1 2026. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • DRW Securities held 7,274 shares of Vera Therapeutics worth $312K as of Q2 2026.
  • DRW Securities sold 1,521 Vera Therapeutics shares in Q2 2026, an estimated $56.7K.
  • Vera Therapeutics made up 0.01% of DRW Securities's portfolio in Q2 2026, its #593 holding.
  • DRW Securities first reported a position in Vera Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • DRW Securities's Vera Therapeutics position peaked at $354K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.